Amount of Special Dividend Payments in 2012 Currently Four Times the Amount Seen in 2011

Five Star Equities Provides Stock Research on Ameren and Pepco Holdings

Continue Reading

Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases

Five Star Equities Provides Stock Research on Neuralstem and Cyclacel Pharmaceuticals

Continue Reading

Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry-s Success in 2012

Five Star Equities Provides Stock Research on StemCells and Aastrom Biosciences

Continue Reading

Special Dividend Payments Increase Fourfold in 2012 as Companies Look to Avoid Upcoming Dividend Tax Increase

Five Star Equities Provides Stock Research on Health Care REIT and R.R. Donnelley & Sons

Continue Reading

Ethanol Stocks Struggle as E15 Fuel Fails to Gain Widespread Adoption

The Paragon Report Provides Stock Research on Green Plains Renewable Energy and Renewable Energy Group

Continue Reading

Recent AAA Survey Shows Just 5% Cars and Trucks in the U.S. Approved to Use E15 Fuel

The Paragon Report Provides Stock Research on BioFuel Energy and Pacific Ethanol

Continue Reading

Copper Prices Soar to 6-Month Highs on Strengthening Chinese Demand

The Paragon Report Provides Stock Research on Teck Resources and Taseko Mines

Continue Reading

The Amount of Companies Paying Special Dividends in 2012 Is Four Times the Pace of 2011

Five Star Equities Provides Stock Research on Verizon and CenturyLink

Continue Reading

Natural Gas Heating Demand Expected to Be 34% Below Average in the Coming Weeks

The Paragon Report Provides Stock Research on EnCana and Cheniere Energy

Continue Reading

Number of Companies Paying Special Dividend Rising Rapidly in 2012 as Dividend Tax Increase Looms

Five Star Equities Provides Stock Research on Lockheed Martin and Pitney Bowes

Continue Reading